Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
Dr. Shin to help advance REN-001 into the clinic by leveraging nearly two decades of...
Search for Articles
Sep 22, 2021
Sep 2, 2021
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...
Sep 1, 2021
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"),...
Aug 25, 2021
Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
PHILADELPHIA, August 25, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing...
Jul 19, 2021
Renovacor Announces the Appointment of Elizabeth White, Ph.D., as Chief Business Officer and Senior Vice President of Operations
PHILADELPHIA, July 19, 2021— Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based...
Jul 15, 2021
Antag Therapeutics appoints Dr. Christine T. Fischette to its Board of Directors
Copenhagen, Denmark, July 15 , 2021 – Antag Therapeutics ApS, a privately-held biotechnology company focused on...